Updated on 23 October 2026
Structural biology expertise for antiviral drug discovery and optimisation (HORIZON-HLTH-2027-01-DISEASE-05)
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain
About
The Protein Crystallography and Structural Immunology Unit at Navarrabiomed (Spain) offers specialised expertise in structural biology and protein engineering to support the development and optimisation of small-molecule antiviral therapeutics targeting pathogens with epidemic potential.
Our platform combines recombinant production of viral or host protein targets in E. coli, Sf9 and CHO systems, ÄKTA-based purification, molecular modelling and X-ray crystallography. Gryphon-assisted crystallisation and routine access to the ALBA synchrotron enable structural studies, while BLI and SPR can characterise binding affinity and kinetics where suitable assay configurations are available.
Within a multidisciplinary consortium, we could contribute to the structural characterisation of viral or host protein targets, the identification and analysis of functional binding pockets, and the structure-guided optimisation of candidate therapeutics. Where experimentally feasible, the determination of protein-ligand complexes could provide valuable mechanistic insights to complement structure-activity relationship (SAR) studies, antiviral assays and resistance investigations conducted by other partners.
We are particularly interested in contributing to work packages focused on target validation, mechanism-of-action studies, molecular modelling and structure-guided lead optimisation, complementing partners with expertise in medicinal chemistry, antiviral testing and preclinical development
Topic
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Irene Pérez López
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Irene Pérez López
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Irene Pérez López
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain